| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.5 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.07 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.084 | 0.08 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.08 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |